ATE494363T1 - Neue cyclooxygenase-varianten und verwendungsverfahren - Google Patents

Neue cyclooxygenase-varianten und verwendungsverfahren

Info

Publication number
ATE494363T1
ATE494363T1 AT02778399T AT02778399T ATE494363T1 AT E494363 T1 ATE494363 T1 AT E494363T1 AT 02778399 T AT02778399 T AT 02778399T AT 02778399 T AT02778399 T AT 02778399T AT E494363 T1 ATE494363 T1 AT E494363T1
Authority
AT
Austria
Prior art keywords
cyclooxygenase
cyclooxygenase type
type
variants
variant
Prior art date
Application number
AT02778399T
Other languages
English (en)
Inventor
Daniel Simmons
Vishvanath N Chandrasekharan
Original Assignee
Univ Brigham Young
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brigham Young filed Critical Univ Brigham Young
Application granted granted Critical
Publication of ATE494363T1 publication Critical patent/ATE494363T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
AT02778399T 2001-09-28 2002-09-28 Neue cyclooxygenase-varianten und verwendungsverfahren ATE494363T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32613301P 2001-09-28 2001-09-28
US37322502P 2002-04-15 2002-04-15
US37366102P 2002-04-16 2002-04-16
US41157502P 2002-09-16 2002-09-16
PCT/US2002/030947 WO2003029411A2 (en) 2001-09-28 2002-09-28 Novel cyclooxygenase variants and methods of use

Publications (1)

Publication Number Publication Date
ATE494363T1 true ATE494363T1 (de) 2011-01-15

Family

ID=27502323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02778399T ATE494363T1 (de) 2001-09-28 2002-09-28 Neue cyclooxygenase-varianten und verwendungsverfahren

Country Status (8)

Country Link
US (2) US7179627B2 (de)
EP (1) EP1463806B1 (de)
JP (1) JP2005534279A (de)
AT (1) ATE494363T1 (de)
AU (1) AU2002340063B2 (de)
CA (1) CA2417455C (de)
DE (1) DE60238872D1 (de)
WO (1) WO2003029411A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US20020187187A1 (en) * 2001-04-21 2002-12-12 Toshimitsu Ohki Fast disintegrating meloxicam tablet
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20040235017A1 (en) * 2003-02-21 2004-11-25 Ning Qin Human cyclooxygenase-3 enzyme and uses thereof
US7198928B2 (en) * 2003-09-15 2007-04-03 Allergan, Inc. Human COX-1 alternatively spliced variants and methods of using same
EP1568369A1 (de) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
CA2623201A1 (en) * 2005-09-30 2007-04-12 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
WO2008106220A1 (en) * 2007-02-28 2008-09-04 Zars Pharma, Inc. Transdermal drug delivery systems for delivery with controlled heat
US20090005745A1 (en) * 2007-06-01 2009-01-01 Jie Zhang Transdermal drug delivery systems for delivering anti-inflammatory drugs
ES3037313T3 (en) * 2009-10-12 2025-09-30 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
CN104102539B (zh) * 2013-04-09 2019-06-28 腾讯科技（深圳）有限公司 获取移动终端应用程序调用的底层库的方法及装置
EP2818177A1 (de) 2013-06-24 2014-12-31 Celica, D.O.O. Mechanismus und Arzneimittelziele zur Senkung des Zellödems (Nervenschutz) und zytoplasmische Erregbarkeit in Astrozyten in normalen und pathologischen Zuständen
WO2018112138A1 (en) * 2016-12-15 2018-06-21 Anavi Goffer Sharon Treatment of mental, movement and behavioral disorders
WO2021054778A1 (ko) * 2019-09-20 2021-03-25 경북대학교 산학협력단 Cox2 단백질의 아세틸화 검출용 항체 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01228479A (ja) * 1988-03-10 1989-09-12 Meiji Milk Prod Co Ltd プロスタグランジンエンドペルオキシドシンテターゼをコードするｄｎａ
US5328470A (en) 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US6048850A (en) 1992-09-22 2000-04-11 Young; Donald A. Method of inhibiting prostaglandin synthesis in a human host
US5543297A (en) * 1992-12-22 1996-08-06 Merck Frosst Canada, Inc. Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity
WO1995009238A1 (en) 1993-09-27 1995-04-06 Merck Frosst Canada Inc. High level expression of human cyclooxygenase-2
US5643960A (en) 1994-04-15 1997-07-01 Duke University Method of delaying onset of alzheimer's disease symptoms
US6025395A (en) 1994-04-15 2000-02-15 Duke University Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
US6043224A (en) 1996-09-05 2000-03-28 The Massachusetts Institute Of Technology Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
JPH10324698A (ja) 1997-03-28 1998-12-08 Takeda Chem Ind Ltd 新規タンパク質およびそのｄｎａ
AU6606500A (en) 1999-08-06 2001-03-05 G.D. Searle & Co. Canine cyclooxygenase-1 (cox-1) and cyclooxygenase-2 (cox-2)
WO2001055301A2 (en) 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2001090125A2 (en) 2000-05-24 2001-11-29 Genaissance Pharmaceuticals, Inc. Haplotypes of the pdxk gene
US6638744B2 (en) * 2000-08-11 2003-10-28 Heska Corporation Canine cox-2 nucleic acid molecules and uses thereof
AU2002258518A1 (en) 2001-03-14 2002-09-24 Millennium Pharmaceuticals, Inc. Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer

Also Published As

Publication number Publication date
US20070065445A1 (en) 2007-03-22
CA2417455A1 (en) 2003-03-27
WO2003029411A2 (en) 2003-04-10
US20030220306A1 (en) 2003-11-27
US7601816B2 (en) 2009-10-13
WO2003029411A3 (en) 2004-08-05
EP1463806A2 (de) 2004-10-06
CA2417455C (en) 2008-01-29
JP2005534279A (ja) 2005-11-17
EP1463806A4 (de) 2006-07-05
AU2002340063B2 (en) 2007-05-10
EP1463806B1 (de) 2011-01-05
DE60238872D1 (de) 2011-02-17
US7179627B2 (en) 2007-02-20

Similar Documents

Publication Publication Date Title
ATE494363T1 (de) Neue cyclooxygenase-varianten und verwendungsverfahren
SE0301009D0 (sv) Novel compounds
NO953601L (no) Nukleinsyre som koder for en tumorreksjonsantigenforlöper
WO2002014485A3 (en) Kallikrein gene
BR0206346A (pt) Proteìnas inseticidas de bacillus thuringiensis
DE50210313D1 (de) Amphotere sterole und deren verwendung
NO20031129D0 (no) Varianter av human koagulasjonsfaktor VII
BR0210358A (pt) Inibidores da protease de hiv, composições contendo os mesmos, seus usos farmacêuticos e materiais para sua sìntese
WO2001010894A3 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
ATE305801T1 (de) Intratumorale verabreichung nackter il-12 codierender nukleinsäuremoleküle
ATE195346T1 (de) Rekombinante dna moleküle die aminopeptidase enzyme kodieren und ihre anwendung für die herstellung von impfstoffen gegen helminth infektionen
WO1994012637A3 (en) Novel human amyloid protein precursor homologue and kunitz-type inhibitors
WO2004019893A3 (en) Modulators of angiogenesis
FI980604A0 (fi) Nya matrismetalloproteinasinhibitorer och -regulatorer
WO2001079167A3 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
AU2001289034A1 (en) Novel pdes and uses thereof
DE60043470D1 (de) Pflanzliche Defensine
Suzuki et al. Primary structure of the virus activating protease: from chick embryo Its identity with the blood clotting factor Xa
Luniak et al. Heterologous expression of the plant cysteine protease bromelain and its inhibitor in Pichia pastoris
WO2003018756A3 (en) Methods for preparing purified prostaglandin e synthase
CY1105275T1 (el) Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda
AR013801A1 (es) Nuevas moleculas de acido nucleico aislada, una proteina de epoxido hidrolasa de artropodo hematofago aislada, una formulacion de proteinas deepoxido hidrolasa de pulga, una composicion terapeutica que reduce la infestacion de ectoparasitos hematofagos; uso de dicha composicion para la
RU2424228C2 (ru) Ингибиторы нейротрипсина
BRPI0407601A (pt) molécula de ácido nucleico, plasmìdeo, composição farmacêutica, uso de nmolécula de ácido nucleico, e método de tratamento ou de prevenção de tumores
DE60120187D1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties